Lobbying Filing Details
Total Spending
$800,000
Activities
3
Lobbyists
5
Gov't Entities
18
Filing Information
- Filing UUID:
af4b53b7-d351-42c5-9fb9-6f823e9b166d- Type:
- Q4 - 4th Quarter - Report
- Period:
- 2013 - 4th Quarter (Oct 1 - Dec 31)
- Date Posted:
- January 17, 2014 at 11:15 PM
- Income:
- $0
- Expenses:
- $800,000
- Expense Method:
- Method A - Reporting amounts using LDA definitions only
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Debra S. Barrett, Senior Vice President for Global Government Affairs and Public Policy
Registrant
TEVA PHARMACEUTICALS USA, INC.
Parsippany, New JerseyClient
TEVA PHARMACEUTICALS USA INC
New Jersey, United States of AmericaLobbying Activities (3)
Activity 1
Copyright/Patent/TrademarkS.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Foreign Entity Issues: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
Lobbyists (5)
- DEBRA BARRETT
- ROBERT FALB
- TERRI STEWART
- GRANT ERDEL
- SUSIE AHN
Government Entities (6)
- SENATE
- HOUSE OF REPRESENTATIVES
- White House Office
- U.S. Trade Representative (USTR)
- Patent & Trademark Office (PTO)
- ... and 1 more
Activity 2
PharmacyPrescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Foreign Entity Issues: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
Lobbyists (5)
- DEBRA BARRETT
- ROBERT FALB
- TERRI STEWART
- GRANT ERDEL
- SUSIE AHN
Government Entities (6)
- SENATE
- HOUSE OF REPRESENTATIVES
- White House Office
- U.S. Trade Representative (USTR)
- Patent & Trademark Office (PTO)
- ... and 1 more
Activity 3
Trade (domestic/foreign)Trans-Pacific Partnership Trade Agreement
Foreign Entity Issues: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
Lobbyists (3)
- DEBRA BARRETT
- TERRI STEWART
- GRANT ERDEL
Government Entities (6)
- SENATE
- HOUSE OF REPRESENTATIVES
- White House Office
- U.S. Trade Representative (USTR)
- Patent & Trademark Office (PTO)
- ... and 1 more
Foreign Entities (3)
ORVET UK
18 Bruntcliffe Way
Contribution: $0
Ownership: 100.0%TEVA PHARMACEUTICALS EUROPE BV
3640 (P.O. Box 306)
Contribution: $0
Ownership: 100.0%TEVA PHARMACEUTICAL INDUSTRIES, LTD.
5 Basel Street, P.O. Box 3190
Contribution: $0
Ownership: 100.0%